HMG-CoA Reductase Inhibitor, Simvastatin Improves Reverse Cholesterol Transport in Type 2 Diabetic Patients with Hyperlipidemia - Concepedia

Concepedia

Publication | Open Access

HMG-CoA Reductase Inhibitor, Simvastatin Improves Reverse Cholesterol Transport in Type 2 Diabetic Patients with Hyperlipidemia

DOI Full Paper Access

35

Citations

16

References

2008

Year

Jingzhi Guan, Naoki Tamasawa, Hiroshi Murakami, Jun Matsui, Jutaro Tanabe, Kota Matsuki, Maki Yamashita, Toshihiro Suda

Journal of Atherosclerosis and Thrombosis

Abstract

Our data suggest that RCT may be reduced in type 2 diabetic patients with hyperlipidemia, and simvastatin may be able to improve reverse cholesterol transport for this population of diabetic patients.

References

	Year	Citations

Page 1